These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
457 related articles for article (PubMed ID: 29079639)
21. Immune Checkpoint Inhibitors: Toward New Paradigms in Renal Cell Carcinoma. Flippot R; Escudier B; Albiges L Drugs; 2018 Sep; 78(14):1443-1457. PubMed ID: 30187355 [TBL] [Abstract][Full Text] [Related]
22. The Evolving Landscape of Immunotherapy-Based Combinations for Frontline Treatment of Advanced Renal Cell Carcinoma. Amin A; Hammers H Front Immunol; 2018; 9():3120. PubMed ID: 30687324 [TBL] [Abstract][Full Text] [Related]
23. Recent advances in the clinical development of immune checkpoint blockade therapy. Ghahremanloo A; Soltani A; Modaresi SMS; Hashemy SI Cell Oncol (Dordr); 2019 Oct; 42(5):609-626. PubMed ID: 31201647 [TBL] [Abstract][Full Text] [Related]
24. PD-1 blockade therapy in renal cell carcinoma: current studies and future promises. Massari F; Santoni M; Ciccarese C; Santini D; Alfieri S; Martignoni G; Brunelli M; Piva F; Berardi R; Montironi R; Porta C; Cascinu S; Tortora G Cancer Treat Rev; 2015 Feb; 41(2):114-21. PubMed ID: 25586601 [TBL] [Abstract][Full Text] [Related]
25. PD-1/PD-L1 blockade in renal cell cancer. Beckermann KE; Johnson DB; Sosman JA Expert Rev Clin Immunol; 2017 Jan; 13(1):77-84. PubMed ID: 27426025 [TBL] [Abstract][Full Text] [Related]
26. Biomarkers for immunotherapy in urological cancers. Gust KM; Resch I; D'Andrea D Curr Opin Urol; 2018 Jan; 28(1):25-28. PubMed ID: 29120910 [TBL] [Abstract][Full Text] [Related]
27. The next generation of immunotherapy: keeping lung cancer in check. Somasundaram A; Burns TF J Hematol Oncol; 2017 Apr; 10(1):87. PubMed ID: 28434399 [TBL] [Abstract][Full Text] [Related]
31. Progress and prospects of immune checkpoint inhibitors in advanced gastric cancer. Zeng Z; Yang B; Liao Z Future Oncol; 2021 Apr; 17(12):1553-1569. PubMed ID: 33397136 [TBL] [Abstract][Full Text] [Related]
32. Immune checkpoint inhibitors in challenging populations. Johnson DB; Sullivan RJ; Menzies AM Cancer; 2017 Jun; 123(11):1904-1911. PubMed ID: 28241095 [TBL] [Abstract][Full Text] [Related]
33. The emerging role of immune checkpoint inhibition in malignant lymphoma. Hude I; Sasse S; Engert A; Bröckelmann PJ Haematologica; 2017 Jan; 102(1):30-42. PubMed ID: 27884973 [TBL] [Abstract][Full Text] [Related]
34. Specific T-cell immune responses against colony-forming cells including leukemic progenitor cells of AML patients were increased by immune checkpoint inhibition. Greiner J; Götz M; Hofmann S; Schrezenmeier H; Wiesneth M; Bullinger L; Döhner H; Schneider V Cancer Immunol Immunother; 2020 Apr; 69(4):629-640. PubMed ID: 32020256 [TBL] [Abstract][Full Text] [Related]
35. Immune checkpoint inhibitors as novel targets for renal cell carcinoma therapeutics. Bailey A; McDermott DF Cancer J; 2013; 19(4):348-52. PubMed ID: 23867517 [TBL] [Abstract][Full Text] [Related]
36. Combination antiangiogenic tyrosine kinase inhibition and anti-PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomes. Laccetti AL; Garmezy B; Xiao L; Economides M; Venkatesan A; Gao J; Jonasch E; Corn P; Zurita-Saavedra A; Brown LC; Kao C; Kinsey EN; Gupta RT; Harrison MR; Armstrong AJ; George DJ; Tannir N; Msaouel P; Shah A; Zhang T; Campbell MT Cancer Med; 2021 Apr; 10(7):2341-2349. PubMed ID: 33650321 [TBL] [Abstract][Full Text] [Related]
37. Patients Selection for Immunotherapy in Solid Tumors: Overcome the Naïve Vision of a Single Biomarker. Signorelli D; Giannatempo P; Grazia G; Aiello MM; Bertolini F; Mirabile A; Buti S; Vasile E; Scotti V; Pisapia P; Cona MS; Rolfo C; Malapelle U; Biomed Res Int; 2019; 2019():9056417. PubMed ID: 31179334 [TBL] [Abstract][Full Text] [Related]
38. Differences in oncological and toxicity outcomes between programmed cell death-1 and programmed cell death ligand-1 inhibitors in metastatic renal cell carcinoma: A systematic review and meta-analysis. Mori K; Pradere B; Quhal F; Katayama S; Mostafaei H; Laukhtina E; Schuettfort VM; D'Andrea D; Egawa S; Bensalah K; Schmidinger M; Powles T; Shariat SF Cancer Treat Rev; 2021 Sep; 99():102242. PubMed ID: 34153830 [TBL] [Abstract][Full Text] [Related]